Yu Fan's Form 4 filing
MedAvail Holdings, Inc. (MDVL) · filed Apr 6, 2022
- Accession no.
- 0000899243-22-014088
- Filed
- Apr 6, 2022, 4:30 PM ET
- Trade date
- Apr 4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $15.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yu FanCIK 0001668029 | 10% Owner |
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.CIK 0001808684 | 10% Owner |
| Ally Bridge Group (NY) LLCCIK 0001822947 | 10% Owner |
| Ally Bridge MedAlpha Master Fund L.P.CIK 0001831963 | 10% Owner |
| ABG Management Ltd.CIK 0001832106 | 10% Owner |
| ABG-WTT Global Life Science Capital Partners GP LtdCIK 0001832108 | 10% Owner |
| ABG-WTT Global Life Science Capital Partners GP, L.P.CIK 0001832109 | 10% Owner |
| ABG WTT-MedAvail LtdCIK 0001832110 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Common Stock | PPurchaseAcquired | +11,143,529 | $1.06 | +$11,839,999.56 | 15,029,480 | Indirect | |
| Apr 4, 2022 | Common Stock | PPurchaseAcquired | +2,974,117 | $1.06 | +$3,159,999.31 | 5,894,897 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Common Stock | PPurchaseAcquired | +5,571,764 | $1.06 | +$5,919,999.25 | 5,571,764 | Indirect | |
| Apr 4, 2022 | Common Stock | PPurchaseAcquired | +1,487,058 | $1.06 | +$1,579,999.13 | 1,487,058 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.